Trending...
- VC Fast Pitch and Steamwork Ventures Bring Startup & Investor Networking Event to Santa Barbara on October 8 - 111
- GitKraken Names Jim Shaw CEO as Software Teams Move From AI Adoption to Multi-Agent Orchestration
- Volant Announces Major Partnership with the STEM Racing Canada Program to CHAMPION YOUTH ENGINEERING
LAS VEGAS, April 25, 2025 ~ Las Vegas, NV - Clarius Mobile Health, a leading company in AI-powered handheld ultrasound technology, has announced the launch of their latest product, Clarius Prostate AI. This FDA-cleared semi-automatic tool is designed to quickly and accurately calculate prostate volume during ultrasound exams. The company will be showcasing this new innovation at the American Urological Association annual meeting from April 26-29.
Prostate volume measurement is crucial in the assessment of common urologic conditions such as Benign Prostatic Hyperplasia (BPH) and prostate cancer. However, current measurement methods rely on manual processes using traditional ultrasound units. With the introduction of Clarius Prostate AI, primary care and urology physicians can now assess patients on the spot without having to wait for specialist referrals.
Sarah Leverett, Vice President of Marketing at Clarius, emphasizes the time-saving potential of AI for physicians who are facing high demand. "Our recent survey showed that 95% of clinicians believe that AI-powered measurements would save them time and allow them to see more patients," she says. "Manual ultrasound prostate volume measurements are repetitive and time-consuming, regardless of experience. With Clarius Prostate AI, what used to take several minutes now takes seconds – no matter your experience level."
More on nvtip.com
Clarius Prostate AI is currently available with Clarius handheld ultrasound scanners that are specifically designed for urology exams. These include the curvilinear C3 HD3 for transabdominal ultrasound and the endocavitary EC7 HD3 – the only FDA-cleared wireless ultrasound for transrectal imaging. These wireless and ultra-portable scanners offer high-definition imaging and performance similar to traditional ultrasound systems but at a fraction of the cost.
During an exam, clinicians can easily activate Prostate AI with a simple tap in the Clarius App on their smartphone or tablet. The tool automatically highlights the prostate gland and places calipers to measure volume when the image is frozen. Clinicians can also manually adjust the calipers for more precise measurements. Additionally, the app calculates PSA density using the entered PSA value and measured volume, allowing for earlier and more informed detection of prostate cancer.
More on nvtip.com
Clarius Prostate AI is just one of the many AI-powered tools offered by Clarius, including Bladder AI and Voice Controls. These tools are available with a Clarius Membership or One-Time License and come with specialized imaging presets, built-in patient reports, and integrated billing codes to streamline workflow in private practice.
"We are excited about the potential of our AI-powered tools to enable more physicians, including primary care physicians, to use ultrasound to identify high-risk prostate cancer patients sooner without relying on a specialist referral," says Sarah Leverett.
Clinicians who are members of Specialty Networks and Afaxys can take advantage of pre-negotiated special pricing and terms for Clarius Prostate AI. This new tool is set to revolutionize prostate volume measurement and improve patient care in urology practices across the country.
Prostate volume measurement is crucial in the assessment of common urologic conditions such as Benign Prostatic Hyperplasia (BPH) and prostate cancer. However, current measurement methods rely on manual processes using traditional ultrasound units. With the introduction of Clarius Prostate AI, primary care and urology physicians can now assess patients on the spot without having to wait for specialist referrals.
Sarah Leverett, Vice President of Marketing at Clarius, emphasizes the time-saving potential of AI for physicians who are facing high demand. "Our recent survey showed that 95% of clinicians believe that AI-powered measurements would save them time and allow them to see more patients," she says. "Manual ultrasound prostate volume measurements are repetitive and time-consuming, regardless of experience. With Clarius Prostate AI, what used to take several minutes now takes seconds – no matter your experience level."
More on nvtip.com
- Soft Water Nevada Announces Labor Day $995 Water Softener & Reverse Osmosis Special for Las Vegas Homeowners
- Boulder City Hospital Awarded $2.65+ Million Rural Health Transformation Initiative Grant
- Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
- Mandeville Pests May Pose Serious Health Risks for Your Family
- Strategic eMarketing Shortlisted for "Top Strategic Industrial Marketing Solutions 2026" Recognition
Clarius Prostate AI is currently available with Clarius handheld ultrasound scanners that are specifically designed for urology exams. These include the curvilinear C3 HD3 for transabdominal ultrasound and the endocavitary EC7 HD3 – the only FDA-cleared wireless ultrasound for transrectal imaging. These wireless and ultra-portable scanners offer high-definition imaging and performance similar to traditional ultrasound systems but at a fraction of the cost.
During an exam, clinicians can easily activate Prostate AI with a simple tap in the Clarius App on their smartphone or tablet. The tool automatically highlights the prostate gland and places calipers to measure volume when the image is frozen. Clinicians can also manually adjust the calipers for more precise measurements. Additionally, the app calculates PSA density using the entered PSA value and measured volume, allowing for earlier and more informed detection of prostate cancer.
More on nvtip.com
- NVision Optix Encourages Year-Round UV Eye Protection for Long-Term Vision Health
- Share your workplace safety solutions at 2027 Applied Ergonomics Conference
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
- May The Worst Team Win! Loserball Kicks Off Another NFL Season of Hilarious Mayhem
- Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
Clarius Prostate AI is just one of the many AI-powered tools offered by Clarius, including Bladder AI and Voice Controls. These tools are available with a Clarius Membership or One-Time License and come with specialized imaging presets, built-in patient reports, and integrated billing codes to streamline workflow in private practice.
"We are excited about the potential of our AI-powered tools to enable more physicians, including primary care physicians, to use ultrasound to identify high-risk prostate cancer patients sooner without relying on a specialist referral," says Sarah Leverett.
Clinicians who are members of Specialty Networks and Afaxys can take advantage of pre-negotiated special pricing and terms for Clarius Prostate AI. This new tool is set to revolutionize prostate volume measurement and improve patient care in urology practices across the country.
0 Comments
Latest on nvtip.com
- As Canada and America Turn on Each Other, These Two Authors Stay On Speaking Terms
- GitKraken Names Jim Shaw CEO as Software Teams Move From AI Adoption to Multi-Agent Orchestration
- Brévant Guide Launches New National Restaurant Guide Across Canada
- Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not
- Mito Health Passes One Million Lab Tests, Expands to Seven Categories of Preventive Health Testing
- VC Fast Pitch and Steamwork Ventures Bring Startup & Investor Networking Event to Santa Barbara on October 8
- Volant Announces Major Partnership with the STEM Racing Canada Program to CHAMPION YOUTH ENGINEERING
- Badanamu and Friends Live Brings Hit Animated Series to Stages Across the United States
- 54 Million Contract. New Chapter as AI Cybersecurity Platform Expands, Margins Surge & Management Signals Confidence. Cycurion, Inc: (NAS DAQ: CYCU)
- MommyAndMe.club Expands Parent-Child Class Directory to All 50 States and Washington, D.C
- Work 365 Deepens TD SYNNEX Integration with Automated Azure Billing
- Tesla AI Engineering Alert: Toroidal Execution Engine Reclaims 40% CPU Overhead for Optimus
- RAS AP Consulting Signals Growth of Managed AP Governance With Digital Expansion, Pipeline Activation, and Trademark Filing Ahead of Esker All Access
- Vegan Kingz Unveils Upgraded Digital Platform to Streamline Commercial Foodservice & Wholesale Ordering
- Steve Thompson Launches StickyHealth to Tackle the Retention Gap in the Growing GLP 1 Market
- Qscription Technologies Appoints Dr. Kimberly Beavers as Founding Clinical Advisor
- When Hope Feels Gone, Death2life Is Still Here!
- Sebastian Stroeller Publishes "The MAP Language Canon" — The Complete Practitioner's Guide to Structural Conversation
- OneVizion Appoints Zebra Technologies CIO Matt Ausman to Board of Directors
- GLADYS Magazine Celebrates their 18 Year Anniversary!